Total Funding
26
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
179008
Flow Forward develops a novel approach to rapidly establish vascular access sites for hemodialysis.
Acquired by 
Artio Medical
- William (Bill) Whitaker: Co-Founder, Legal Consultant, Corporate Secretary, DirectorPast Role: Novita Therapeutics, VP Finance / General Counsel / Founder
About the Company
Flow Forward Medical develops vascular access sites designed to improve post-surgery success rates. The Arteriovenous Fistula Eligibility (AFE) System is a small, temporary, external blood pump designed to stimulate flow-mediated dilation to make more patients eligible for arteriovenous fistula (AVF) and increase success rates after surgery. The
establishment of a reliable AVF reduces morbidity and mortality in hemodialysis patients, as well as the overall cost of care.
The company was founded in 2014 by Frank Nicholas Franano and is headquartered in Olathe, Kansas.
